OnabotulinumtoxinA for chronic migraine treatment: 75% responder analysis from double-blind, randomized, placebo-controlled phase of PREEMPT

por Dodick, D, Diener, HC, Turkel, C, DeGryse, R, Brin, M
Publicado 2013

Gr1(int/high) Cells Dominate the Early Phagocyte Response to Mycobacterial Lung Infection in Mice

por Ryder, Brin M., Sandford, Sarah K., Manners, Kate M., Dalton, James P., Wiles, Siouxsie, Kirman, Joanna R.
Publicado 2019

Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine

por Diener, H-C, Dodick, D W, Turkel, C C, Demos, G, DeGryse, R E, Earl, N L, Brin, M F
Publicado 2014